HomeGUD • TSE
add
Knight Therapeutics Inc
Previous close
$5.34
Day range
$5.30 - $5.35
Year range
$5.09 - $6.23
Market cap
533.56M CAD
Avg Volume
65.74K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 92.26M | 13.21% |
Operating expense | 41.81M | 6.53% |
Net income | 85.00K | -99.11% |
Net profit margin | 0.09 | -99.23% |
Earnings per share | — | — |
EBITDA | 16.59M | 13.43% |
Effective tax rate | 86.02% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 172.32M | 7.75% |
Total assets | 962.29M | -4.83% |
Total liabilities | 188.38M | -4.12% |
Total equity | 773.91M | — |
Shares outstanding | 100.80M | — |
Price to book | 0.70 | — |
Return on assets | 0.84% | — |
Return on capital | 0.97% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 85.00K | -99.11% |
Cash from operations | 5.02M | -66.93% |
Cash from investing | 11.53M | -67.76% |
Cash from financing | -3.93M | 65.06% |
Net change in cash | 12.95M | -67.28% |
Free cash flow | 1.02M | 121.60% |
About
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Founded
2014
Headquarters
Website
Employees
725
